Natriuretic Peptide Market, Global Outlook and Forecast 2025-2032

Page 1


Report Overview:

 Natriuretic peptides are a group of hormones predominantly produced by the heart in response to increased blood volume and pressure. These peptides, including A-type natriuretic peptide (ANP), B-type natriuretic peptide (BNP), and C-type natriuretic peptide (CNP), play a vital role in regulating cardiovascular function. Their primary function is to help the body maintain fluid balance and regulate blood pressure by promoting natriuresis (the excretion of sodium through urine), vasodilation (widening of blood vessels), and inhibiting the production of renin and aldosterone. In essence, natriuretic peptides counteract the effects of the renin-angiotensin-aldosterone system (RAAS), which helps to lower blood pressure and reduce the strain on the heart.

 These hormones are important markers in diagnosing heart failure and assessing the risk of cardiovascular diseases. Therefore, they are often utilized in medical diagnostics, particularly in assays for the detection of abnormal natriuretic peptide levels in patients.

Market Value:

 The global natriuretic peptide market was valued at USD 198 million in 2024, and it is anticipated to reach USD 218.49 million by 2032. This reflects a steady growth trajectory with a Compound Annual Growth Rate (CAGR) of 1.10% during the forecast period. CAGR of 1.10% (2025 – 2032)

By Types:

• 0.1-1000 pg/Ml

• 0.31-20 ng/Ml

By Applications: Medical Care

Laboratory

Key players include:

• Raybiotech

• Aviva Systems Biology

• AssayPro

• Biomatik

• Novus Biologicals

• Including or Excluding key companies relevant to your analysis.

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.